As central nervous system (CNS) research faces gaps in cell-model relevance and functional testing, Creative Biolabs offers primary neuronal cultures, hippocampal assays, and human astrocytes to support rigorous study design.
Can a compound keep neurons alive yet fail to protect their function? In central nervous system (CNS) drug discovery, viability results alone may miss changes in electrical activity, synaptic plasticity, and interactions between neurons and glial cells. Combined with variability in primary cultures, these blind spots complicate early evaluations of candidate compounds. Creative Biolabs provides complementary neuronal models, functional assays, and human astrocytes to help researchers design more informative in vitro studies.
Immortalized cell lines offer convenience and scalability, but may not reproduce the specialized behaviour of neurons from defined brain regions. Primary cultures provide a closer view of native neuronal biology, though isolation procedures, cell composition, and culture maturity can influence results.
Creative Biolabs’ primary neuronal cell culture models support research using cells from regions such as the hippocampus and cortex. Depending on the study, investigators can explore neuron-only cultures or co-culture approaches involving glial cells. Protein and gene-expression analysis can be paired with microscopy, calcium imaging, or electrophysiological measurements to examine biological responses from different perspectives.
A positive result in a viability assay does not necessarily indicate preserved neuronal communication. This distinction is critical when evaluating disease mechanisms and potential therapeutics for Alzheimer’s disease, epilepsy, and other neurological conditions.
Through its primary hippocampal neuron culture and assay services, Creative Biolabs supports investigations into neuronal toxicity, neurite development, and synaptic plasticity. Researchers can select from cell viability and neuronal death assays, calcium assays, multielectrode array (MEA) measurements, and neuroprotective compound screening according to their hypotheses.
For example, pairing a toxicity endpoint with an activity-based measurement can help distinguish apparent cell survival from changes in neuronal function. Defining these endpoints before screening also makes findings easier to interpret and compare across experiments.
Neuronal activity depends heavily on the surrounding cellular environment. Astrocytes help maintain homeostasis, modulate synaptic signalling, and participate in responses to injury. Models that exclude them may overlook mechanisms relevant to neuroinflammation and neurodegenerative disease.
Creative Biolabs also provides primary human astrocytes isolated from the cerebral cortex. These cryopreserved, glial fibrillary acidic protein (GFAP)-positive cells offer a human glial model for studying astrocyte function and cellular interactions. When designing co-culture studies, researchers should account for cell origin, species compatibility, culture conditions, and the limitations of the selected system.
Rather than relying on one model or readout, the practical priority is to align cell types, experimental controls, and functional endpoints with the biological question. This fit-for-purpose approach can support stronger early-stage decisions without overstating what any in vitro model can predict.
Researchers developing CNS disease models or evaluating neuroactive compounds can explore Creative Biolabs’ neuroscience research solutions, or contact the neuroscience team to discuss suitable study designs.
About Creative Biolabs
Creative Biolabs supplies neuroscience research services, specialized cellular models, functional assays, and laboratory reagents to academic, biotechnology, and pharmaceutical researchers investigating CNS biology and therapeutic development.
